Worth reading
50Recurring
Scored from 4 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
364800
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Issuance of stock acquisition rights as equity compensation stock options
Who receives how much
364,800 common shares (3,648 stock acquisition rights, 100 shares per right)
3 of the Company's directors, excluding outside directors364,800 shares (3,648 stock acquisition rights)
The lower thin line represents the existing number of shares to which these shares will be added.
Not applicable (no monetary payment is required in exchange for the stock acquisition rights)
Amount of funds to be raised
Not applicable (no monetary payment is required in exchange for the stock acquisition rights)
Specific use of funds
Not applicable (the stock acquisition rights are issued for compensation purposes and no payment to the Company is required)
Terms of the stock acquisition rights
Exercise price
The initial exercise price is ¥1 per share. The adjustment provisions linked to the share price and the floor for such adjustments are Not disclosed
Exercise period
26 March 2029 to 25 March 2036
Number of Stock Acquisition Rights
Total number issued: 3,648. Number of outstanding unexercised rights: Not disclosed
Reason for acquisition without consideration
If approval or other authorization is obtained at a shareholders' meeting for a corporate reorganization or similar transaction, or if a stock acquisition rights holder becomes unable to exercise the rights under the exercise conditions, the Company may acquire the rights at no cost.
Offering structure
Underwriter / lead underwriter
None
Overallotment
None
Categories and Number of Persons Covered
3 of the Company's directors, excluding outside directors; 3,648 rights (364,800 shares)
Payment date
None
Basis for determining the amount to be paid
The exercise price is ¥1 per share. The stock acquisition rights themselves will be issued at no cost. The closing price and average share price used as the basis, and the discount or premium rate, are Not disclosed
Procedures under the Corporate Code of Conduct
The issuance was resolved by the Board of Directors pursuant to Articles 236, 238 and 240 of the Companies Act.
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of stock acquisition rights as equity compensation stock options |
| Number of shares to be issued or disposed of | 364,800 common shares (3,648 stock acquisition rights, 100 shares per right) |
| Issue price and disposal price | Not applicable (no monetary payment is required in exchange for the stock acquisition rights) |
| Amount of funds to be raised | Not applicable (no monetary payment is required in exchange for the stock acquisition rights) |
| Specific use of funds | Not applicable (the stock acquisition rights are issued for compensation purposes and no payment to the Company is required) |
| Payment date | None |
| Intended allottee | Name 3 of the Company's directors, excluding outside directors / Number of Shares 364,800 shares (3,648 stock acquisition rights) |
| Basis for determining the amount to be paid | The exercise price is ¥1 per share. The stock acquisition rights themselves will be issued at no cost. The closing price and average share price used as the basis, and the discount or premium rate, are Not disclosed |
| Exercise price | The initial exercise price is ¥1 per share. The adjustment provisions linked to the share price and the floor for such adjustments are Not disclosed |
| Exercise period | 26 March 2029 to 25 March 2036 |
| Number of Stock Acquisition Rights | Total number issued: 3,648. Number of outstanding unexercised rights: Not disclosed |
| Reason for acquisition without consideration | If approval or other authorization is obtained at a shareholders' meeting for a corporate reorganization or similar transaction, or if a stock acquisition rights holder becomes unable to exercise the rights under the exercise conditions, the Company may acquire the rights at no cost. |
| Categories and Number of Persons Covered | 3 of the Company's directors, excluding outside directors; 3,648 rights (364,800 shares) |
| Underwriter / lead underwriter | None |
| Overallotment | None |
| Procedures under the Corporate Code of Conduct | The issuance was resolved by the Board of Directors pursuant to Articles 236, 238 and 240 of the Companies Act. |
Items this document does not state (12)
Total issue valueEstimated issuance expensesIntended allottee's holding policyDilution RateTotal number of issued sharesTransfer restriction periodConditions for lifting transfer restrictionsTotal Stock-Based CompensationStock Split RatioMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To share with shareholders the benefits and risks of share price movements and provide stronger-than-ever incentives to improve long-term performance and enhance corporate value.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.